company 617 words
Contents

Dopamine Transporter Modulators for Parkinson's Disease

No AI portrait yet

Agent Input

💡 Improve this page

🌐 Cross-references

CrunchbaseWikipedia

Related Hypotheses (109)

Mitochondrial SPM Synthesis Platform Engineering
Score: 0.65
Gamma entrainment therapy to restore hippocampal-cortical sy
Score: 0.90
AMPK hypersensitivity in astrocytes creates enhanced mitocho
Score: 0.82
Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna
Score: 0.82
Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.79
Selective TLR4 Modulation to Prevent Gut-Derived Neuroinflam
Score: 0.79
Competitive APOE4 Domain Stabilization Peptides
Score: 0.78
Selective HDAC3 Inhibition with Cognitive Enhancement
Score: 0.78
Prefrontal sensory gating circuit restoration via PV interne
Score: 0.78
Dual-Domain Antibodies with Engineered Fc-FcRn Affinity Modu
Score: 0.77
Circadian Clock-Autophagy Synchronization
Score: 0.76
Transcriptional Autophagy-Lysosome Coupling
Score: 0.76
Multi-Modal Stress Response Harmonization
Score: 0.76
Circadian-Synchronized Proteostasis Enhancement
Score: 0.74
Smartphone-Detected Motor Variability Correction
Score: 0.74
Senescent Cell Mitochondrial DNA Release
Score: 0.74
Near-infrared light therapy stimulates COX4-dependent mitoch
Score: 0.74
PARP1 Inhibition Therapy
Score: 0.74
Senescence-Associated Myelin Lipid Remodeling
Score: 0.73
CYP46A1 Overexpression Gene Therapy
Score: 0.73
pg 1/6Next →

Related Analyses (30)

Selective vulnerability of entorhinal cortex layer II neuron
neurodegeneration · archived
Epigenetic reprogramming in aging neurons
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · completed
Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed
Sleep disruption as cause and consequence of neurodegenerati
neurodegeneration · archived

Related Experiments (30)

ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40
TREM2 Agonist Therapy for Parkinson's Disease — Experimental
validation · proposed · Score: 0.45
AAV Serotype Comparison for LRRK2 Knockdown in PD
validation · proposed · Score: 0.40
Alpha-Synuclein SAA Kinetics Study — Biological Staging Back
clinical · proposed · Score: 0.40
Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio
clinical · proposed · Score: 0.40

See Also (13)

Striatum
brain · KG edge: expressed_in
Parkinson Basal Ganglia Circuit
circuit · KG edge: loss_affects
NeuRon Therapeutics
company · KG edge: loss_affects
Neurodegeneration
disease · KG edge: loss_affects
acetylcholine
general · KG edge: co_discussed

Knowledge Graph (8 edges)

FYN causes Dopaminergic
STAT3 activates Dopaminergic
IL1B activates Dopaminergic
TNFA activates Dopaminergic
IL12A activates Dopaminergic
DEPRESSION associated_with Dopaminergic
STAT3 therapeutic_target Dopaminergic
ASTROCYTE therapeutic_target Dopaminergic

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

💬 Discussion (Talk page)

Loading comments...
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.